Cyclophilin a: A key factor in virus replication and potential target for anti-viral therapy

Current Issues in Molecular Biology

Volumn 21, Issue , 2017, Pages 1-20

  Dawar, Farman Ullah ^a   Tu, Jiagang ^a   Khattak, Muhammad Nasir Khan ^b   Mei, Jie ^a   Lin, Li ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b HAZARA UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALISPORIVIR; ANTIVIRUS AGENT; CD147 ANTIBODY; CPI 431 32; CYCLOPHILIN A; CYCLOSPORIN; CYCLOSPORIN A; CYCLOSPORIN A [4 N METHYLISOLEUCINE]; CYCLOSPORIN D; CYCLOSPORIN G; LEAD 25; NITD 008; SCY 635; TACROLIMUS; TELBIVUDINE; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIVIRAL THERAPY; ARTICLE; CORONAVIRIDAE; CORONAVIRIDAE INFECTION; CYTOMEGALOVIRUS INFECTION; DRUG TARGETING; ENTEROVIRUS; ENTEROVIRUS INFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; INFLUENZA A; INFLUENZA A VIRUS; NONHUMAN; PROTEIN FUNCTION; PROTEIN TARGETING; ROTAVIRUS; ROTAVIRUS INFECTION; VACCINIA VIRUS; VESICULAR STOMATITIS; VESICULOVIRUS; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; PROCEDURES; VIROLOGY; VIRUS INFECTION;

ANTIVIRAL AGENTS; CYCLOPHILIN A; HOST-PATHOGEN INTERACTIONS; HUMANS; MOLECULAR TARGETED THERAPY; VIRUS DISEASES; VIRUS REPLICATION;

EID: 84962077763     PISSN: 14673037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (166)

1. Aberham, C., Weber, S., and Phares, W. (1996). Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. Journal of Virology 70, 3536-3544.
2. Adriaan, H., Wilde, D., Jessika C., Zevenhoven-Dobbe, Meer Y.V.D., Thiel, V., Narayanan, K., Makino, S., Snijder, E.J., and Hemert, M.J.V. (2011). Cyclosporin A inhibits the replication of diverse coronaviruses. Journal of General Virology 92, 2542-2548.
3. Agresta, B.E., and Carter, C. (1997). Cyclophilin a induced alterations of human immunodeficiency virus type 1 CA protein in vitro. Journal of Virololgy 71, 6921-6927.
4. Alexanian, A.R., and Bamburg, J.R. (1999). Neuronal survival activity of s100bb is enhanced by calcineurin inhibitors and requires activation of NF-kB. The FASEB Journal 13, 1611-1620.
5. Bagchi, P., Dutta, D., Chattopadhyay, S., and Mukherjee, A. (2010). Rotavirus nonstructural protein 1 suppresses virus-induced cellular apoptosis to facilitate viral growth by activating the cell survival pathways during early stages of infection. Journal of Virology 84, 6834-6845.
6. Banerjee, A. K. (1987). Transcription and replication of rhabdoviruses. Microbiology reviews 51, 66-87.
7. Bauer, K., Kretzschmar, A.K., Cvijic, H., Blumert, C., Löffler, D., Brocke-Heidrich, K., Schiene-Fischer, C., Fischer, G., Sinz, A., Clevenger, C.V., and Horn, F. (2009). Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells. Oncogene 28, 2784-2795.
8. Bienkowska-Haba, M., Williams, C., Kim, S.M., Garcea, R.L., and Sapp, M. (2012). Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry. Journal of Virology 86, 9875-9887.
9. Bose, S., Mathur, M., Bates, P., Joshi, N. and Banerjee, A. K. (2003). Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype. Journal of General Virology 84, 1687-1699.
10. Brazin, K.N., Mallis, R.J., Fulton, D.B. and Andreotti, A.H. (2002). Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proceedings of the National Academy of Sciences of the United States of America 99, 1899-1904.
11. Bruns, K., Fossen, T., Wray, V., Henklein, P., Tessmer, U., and Schubert, U. (2003). Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism. The Journal of Biological Chememistry 278, 43188-43201.
12. Carbajo-Lozoyaa, J., Ma-Lauer, Y., Malésevíc, M., Theuerkorn, M., Kahlert, V., Prell, E., von Brunn, B., Muth, D., Baumert, T.F., Drosten, C., Fischer, G., and von Brunn, A. (2014). Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by nonimmunosuppressive cyclosporine A-derivatives including Alisporivir. Virus Research 184, 44-53.
13. Castro, A.P.V., Carvalho, T.M.U., Moussatché, N., and Damaso, C.R.A. (2003). Redistribution of Cyclophilin A to Viral Factories during Vaccinia Virus Infection and Its Incorporation into Mature Particles. Journal of virology 77, 9052-9068.
14. Chatterji, U., Bobardt, M., Selvarajah, S., Yang, F., Tang, H., Sakamoto, N., Vuagniaux, G., Parkinson, T., and Gallay, P. (2009). The isomerase active site of cyclophilin A is critical for hepatitis C virus replication. The Journal of Biological Chemistry 284, 16998-7005.
15. Chatterji, U, Lim, P., Bobardt, M.D., Wieland, S., Cordek, D.G., Vuagniaux, G., Chisari, F., Cameron, C.E., Targett-Adams, P., Parkinson, T., and Gallay, P.A. (2010). HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors. Journal of Hepatology 53, 50-56.
16. Chen, S., Zhang, M., Ma, H., Saiyin, H., Shen, S., Xi, J., Wan, B., and Yu, L. (2008). Oligomicroarray analysis reveals the role of cyclophilin A in drug resistance. Cancer Chemotherapy and Pharmacology 61, 459-469.
17. Chen, Z., Mi, L., Xu, J., Yu, J., Wang, X., Jiang, J., Xing, J., Shang, P., Qian, A., Li, Y., Shaw, PX., Wang, J., Duan, S., Ding, J., Fan, C., Zhang, Y., Yang, Y., Yu, X., Feng, Q., Li, B., Yao, X., Zhang, Z., Li, L., Xue, X., and Zhu, P. (2005). Function of HAb18G/CD147 in Invasion of Host Cells by Severe Acute Respiratory Syndrome Coronavirus: The Journal of Infectious Diseases 191, 755-60.
18. Choi, K.J., Piao, Y.J., Lim, M.J., and Kim, J. H. (2007). Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death. Cancer Research 67, 3654-3662.
19. Chong, D.D., and Rose, J.K. (1993). Membrane association of functional vesicular stomatitis virus matrix protein in vivo. Journal of Virology 67, 407-414.
20. Ciesek, S., Steinmann, E., Wedemeyer, H., Manns, M.P., Neyts, J., Tautz, N., Madan, V., Bartenschlager, R., von Hahn, T., and Pietschmann, T. (2009). Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A. Hepatology 50, 1638-1645.
21. Coelmont, L., Kaptein, S., Paeshuyse, J., Vliegen, I., Dumont, J.-M., Vuagniaux, G. and Neyts, J. (2009). Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STATC) inhibitors. Antimicrobial Agents and Chemotherapy 53, 967-976.
22. Colgan, J., Asmal, M., Neagu, M., Yu, B., Schneidkraut, J., Lee, Y., Sokolskaja, E., Andreotti, A., and Luban, J. (2004). Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity 21, 189-201.
23. Colgan, J., Yuan, H.E., Franke, E.K., and Luban, J. (1996). Binding of the human immunodeficiency virus type 1 Gag polyprotein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. Journal of Virology 70,4299-4310.
24. Cortines, J.R., Lima, T.R. L.M., Mohana-Borges, R., Millen, T.A., Gaspar, LP., Lanman, JK., Prevelige P.E. Jr., and Silva, J.L. (2015). Structural insights into the stabilization of the human immunodeficiency virus type 1 capsid protein by the cyclophilin-binding domain and implications on the virus cycle. Biochimica et Biophysica Acta 1854, 341-348.
25. Damaso, C.R., and Moussatché, N. (1998). Inhibition of vaccinia virus replication by cyclosporin A analogues correlates with their affinity for cellular cyclophilins. Journal of General Virology 79,339-346.
26. Dandri, M., and Locarnini, S. (2012). New insight in the pathobiology of hepatitis B virus infection. Gut. 61, 6-17.
27. Davis, T.L., Walker, J.R., Campagna-Slater, V., Finerty, P.J., Paramanathan, R., Bernstein, G., MacKenzie, F., Tempel, W., Ouyang, H., Lee, W.H., Eisenmesser, E.Z., and Dhe-Paganon, S. (2010). Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. PLoS Biology 8, e1000439.
28. De, B.P., Thornton, G.B., Luk, D., and Banerjee, A.K. (1982). Purified matrix protein of vesicular stomatitis virus blocks viral transcription in vitro. Proceedings of the National Academy of Sciences of the United States of America. 79, 7137-7141.
29. Dennehy, P. H. (2005). Rotavirus vaccines: an update. Curr. Opin. Pediatr. 17, 88-92.
30. Dolinski, K., and Heitman, J. (1997). Peptidylprolyl isomerases—an overview of the cyclophilin, FKBP and parvulin families, p. 359-369. In M.-J. Gething (ed.), Guidebook to molecular chaperones and protein-folding catalysts. Oxford University Press, Oxford, England.
31. Dong, X., Qin, Z., Hu, X., Lan, J., Yuan, G., Asim, M., Zhou, Y., Ai, T., Mei, J., and Lin, L. (2015). Molecular cloning and functional characterization of cyclophilin A in yellow catfish (Pelteobagrus fulvidraco). Fish and Shellfish Immunology. 45, 422-430.
32. Dorner, M., Horwitz, J.A., Donovan, B.M., Labitt, R.N., Budell, W.C., and Friling, T., (2003).Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature. 501, 237-241.
33. Evans, M.J., Rice, C.M., Goff S.P. (2004). Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proceedings of the National Academy of Sciences of the United States of America 101,13038-13043.
34. Fields, B.N., Knipe, D.M., Howley, P.M., Griffin, D.E., (2001). Fields Virology. Lippincott Williams & Wilkins, Philadelphia (3087, 72 pp.).
35. Fischer, G., and Aumüller, T. (2003). Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Reviews of Physiology, Biochemistry and Pharmacology 148, 105-150.
36. Flisiak, R., Feinman, S.V., Jablkowski, M., Horban, A., Kryczka, W., Pawlowska, M., Heathcote, J. E., Mazzella, G., Vandelli, C., Nicolas-Métral, V., Grosgurin, P., Liz, J.S., Scalfaro, P., Porchet, H., and Crabbé, R. (2009). The cyclophilin inhibitor Debio 025 combined with PEG IFNa2a significantly reduces viral load in treatment-naı¨ve hepatitis C patients. Hepatology 49, 1460-1468.
37. Flückiger, S., Fijten, H., Whitley, P., Blaser, K., and Crameri, R. (2002). Cyclophilins, a new family of cross-reactive allergens. Eur. Journal of Immunology 32, 10-17.
38. Foster, T.L., Gallay, P., Stonehouse, N.J., and Harris, M. (2011). Cyclophilin A interacts with domain II of hepatitis C virus NS5A and stimulates RNA binding in an isomerase-dependent manner. Journal Virology 85, 7460-7464.
39. Freskgard, P.O., Bergenhem, N., Jonsson, B.H., Svensson, M., and Carlsson, U. (1992). Isomerase and chaperone activity of prolyl isomerase in the folding of carbonic anhydrase. Science 258, 466-468.
40. Friedman, J., and Weissman, I. (1991). Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell 66,799-806.
41. Fruman, D.A., Burakoff, S.J., and Bierer, B.E. (1994). Immunophilins in protein-folding and immunosuppression. The FASEB journal 8, 391-400.
42. Gallay, P.A., Bobardt, M.D., Chatterji, U., Trepanier, D.J., Ure, D., Ordonez, C., and Foster, R. (2015). The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action. PLoS ONE 10, e0134707.
43. Gamble, T.R., Vajdos, F.F., Yoo, S., Worthylake, D.K., Houseweart, M., Sundquist, W.I, and Hill, C.P. (1996). Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell 87,1285-94.
44. Ganser-Pornillos, B.K., Yeager, M., and Sundquist W.I., (2008). The structural biology of HIV assembly. Current Opinion in Structural Biology 18, 203-217.
45. Goldstone, D.C., Yap, M.W., Robertson, L.E., Haire, L.F., Taylor, W.R., Katzourakis, A., Stoye, J.P., and Taylor, I.A. (2010). Structural and functional analysis of prehistoric lentiviruses uncovers an ancient molecular interface. Cell Host and Microbe 8, 248-259.
46. Göthel, S.F., and Marahiel, M.A., (1999). Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cellular and Molecular Life Sciences 55, 423-436.
47. Goujon, C., Moncorge, O., Bauby, H., Doyle, T., Ward, C.C., Schaller, T., Hué, S., Barclay, W.S., Schulz, R., and Malim, M.H. (2013). Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502, 559-62
48. Guan, Y., Zheng, B.J., He, Y.Q., Liu, X.L., Zhuang, Z.X., Cheung, C.L., Luo, S.W., Li, P.H., Zhang, L.J., Guan, Y.J., Butt, K.M., Wong, K.L., Chan, K.W., Lim, W., Shortridge, K.F., Yuen, K.Y., Peiris, J.S., and Poon, L.L. (2003). Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302, 276-278.
49. Gwinn, M.W., Damsker, J.M., Falahati, R., Okwumabua, I., Kelly-Welch, A., Keegan, A.D., Vanpouille, C., Lee, J.J., Dent, L.A., Leitenberg, D., Bukrinsky, M.I., and Constant, S.L., (2006). Novel Approach to Inhibit Asthma-Mediated Lung Inflammation Using Anti-CD147 Intervention1. The Journal of Immunology 177, 4870-4879.
50. Hamamoto, I., Harazaki, K., Inase, N., Takaku, H., Tashiro, M., and Yamamoto, N. (2013). Cyclosporin A Inhibits the Propagation of Influenza Virus by Interfering with a Late Event in the Virus Life Cycle Jpn. Journal of Infecteus Disease 66, 276-283.
51. Hamamoto, I., Nishimura, Y., Okamoto, T., Aizaki, H., Liu, M., Mori, Y., Abe, T., Suzuki, T., Lai, M.M., Miyamura, T., Moriishi, K., and Matsuura, Y. (2005). Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. Journal of Virology 79, 13473-13482.
52. Harty, R.N., Brown, M.E., McGettigan, J.P., Wang, G., Jayakar, H.R., Huibregtse, J.M., Whitt, M.A., and Schnell, M.J. (2001). Rhabdoviruses and the cellular ubiquitin-proteasome system: a budding interaction. Journal of Virology 75, 10623-10629.
53. Hatziioannou, T., Perez-Caballero, D., Cowan, S., and Bieniasz, P.D. (2005). Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. Journal of Virology 79, 176-183.
54. He, H., Zhou, D., Fan, W., Fu, X., Zhang, J., Shen, Z., Li, J., and Wu, Y. (2012). Cyclophilin A inhibits rotavirus replication by facilitating host IFN-I production. Biochemical and Biophysical Research Communication 422, 664-669.
55. He, H., Mou, Z., Li, W., Fei, L., Tang, Y., Zhang, J., Yan, P., Chen, Z., Yang, X., Shen, Z., Li, J., and Wu, Y. (2013). Proteomic methods reveal cyclophilin A function as a host restriction factor again strota virus in fection. Proteomics 13,1121-32.
56. Hoffmann, H., and Schiene-Fischer, C. (2014). Functional aspects of extracellular cyclophilins. Biological Chemistry 395, 721-735.
57. Hopkins, S., DiMassimo, B., Rusnak, P., Heuman, D., Lalezari, J., Sluder, A., Scorneaux, B., Mosier, S., Kowalczyk, P., Ribeill, Y., Baugh, J., and Gallay, P. (2012). The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection. Journal of Hepatology 57, 47-54.
58. Hopkins, S., Heuman, D., Gavis, E., Lalezari, J., Glutzer, E., DiMasso, B., Rusnak, P., Wring, S., Smitley, S., and Ribeill, Y. (2009). SCY-635 Demonstrates Clinically Relevant Single-agent Results in a Phase 1b Study in Adults with HCV. 44th Annual Meeting of the European Association for the Study of the Liver. Copenhagen, Denmark. Abstract 89.
59. Horvth, R., Cerny, J., Benedík, J., Hökl, J., Jelínková, I. and Benedík, J. (2000). The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. Journal of Clinical Virology 16, 17-24.
60. Huang, S.W., Cheng, H.L., Hsieh, H.Y., Chang, C.L., Tsai, H.P., Kuo, P.H., Wang, S.M., Liu, C.C., Su, I.J., and Wang, J.R. (2014). Mutations in the non-structural protein region contribute to intra-genotypic evolution of Enterovirus 71. Journal of Biomedical Sciences 10, 21-33.
61. Jain, J., Mecaffrey, P.G., Miner, Z., Kerppola, T.K., Lamberts, J.N., Verdine, G.L., Curran, T., and Rao, A. (1993) The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature, 365, 352-355
62. Jayaram, H., Estes, M. K., and Prasad, B. V., (2004). Emerging themes in rotavirus cell entry, genome organization, transcription and replication. Virus Research 101, 67-81.
63. Jiao, M., Nan, K.J., (2011). Activation of PI3 kinase/Akt/HIF-1 alpha pathway contributes to hypoxia-induced epithelialmesenchymal transition and chemoresistance in hepatocellular carcinoma. International Journal of Oncology 40, 461-468.
64. Jin, Z.G., Lungu, A.O., Xie, L., Wang, M., Wong, C., and Berk, B.C. (2004). Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 24, 1186-91.
65. Joklik, W.K., and Becker Y., (1964). The replication and coating of vaccinia DNA. Journal of Molecular Biology 10, 452-474.
66. Kaul, A., Stauffer, S., Berger, C., Pertel, T., Schmitt, J., Kallis, S., Zayas, M., Lohmann, V., Luban, J., and Bartenschlager, R. (2009). Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathogens 5, e1000546.
67. Kawasaki, H., Mocarski, E.S., Kosugi, I., and Tsutsui, Y. (2007). Cyclosporine inhibits mouse cytomegalovirus infection via a cyclophilindependent pathway specifically in neural stem/progenitor cells. Journal of Virology 81, 9013-9023.
68. Kern, D., Drakenberg, T., Wikstrom, M., Forsen, S., Bang, H., and Fischer G. (1993). The cis/trans interconversion of the calcium regulating hormone calcitonin is catalyzed by cyclophilin. FEBS Letter 323, 198-202.
69. Kern, G., Kern, D., Schimid, F.X., and Fischer, G. (1994). Reassessment of the putative chaperone function of prolyl cis/trans-isomerase. FEBS Letter 348,145-148.
70. Kim, H., Kim, W.J., Jeon, S.T., Koh, E.M., Cha, H.S., Ahn, K.S., and Lee, W.H. (2005). Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from marcrophages. Clinical Immunology 116, 217-224.
71. King, T.P., Hoffman, D., Lowenstein, H., Marsh, D.G., Platts-Mills, T.A.E., and Thomas, W. (1995). Allergen nomenclature. International archives of Allergy and Immunology 95, 5-14.
72. Kontoyiannis, D.P., Pasqualini, R., Arap, W. (2003). Aminopeptidase N inhibitors and SARS. The LANCET 361, Pag3 1558.
73. Krummrei, U., Bang, R., Schmidtchen, R., Brune, K., and Bang, H. (1995). Cyclophilin-A is a zinc-dependent DNA binding protein in macrophages. FEBS Letters 371, 47-51.
74. Kunz, J., and Hall, M.N. (1993). Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. Trends in Biochemical Sciences 18, (9):334-338.
75. Lawitz, E., Godofsky, E., Rouzier, R., Marbury, T., Nguyen, T., Ke, J., Huang, M., Praestgaard, J., Serra, D., and Evans, T.G. (2011). Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCVinfected patients receiving 14 days of therapy. Antiviral Research 89, 238-245.
76. Lee, J., (2013). Cyclophilin A as a New Therapeutic Target for Hepatitis C Virus-induced Hepatocellular Carcinoma. Korean Journal of Physiology and Pharmacology 17, 375-83.
77. LeHir, M., Su, Q., Weber, L., Woerly, G., Granelli-Piperno, A., and Ryffel B. (1995). In situ detection of cyclosporin A: evidence for nuclear localization of cyclosporine and cyclophilins. Laboratory Investigations 73, 727-733.
78. Li, J., Chen, J., Zhang, L., Wang, F., Gui, C., Zhang, L., Qin, Y., Xu, Q., Liu, H., Nan, F., Shen, J., Bai, D., Chen, K., Shen, X., and Jiang, H. (2006). One novel quinoxaline derivative as a potent human cyclophilin A inhibitor shows highly inhibitory activity against mouse spleen cell proliferation. Bioorganic and Medicinal Chemistry 14, 5527-5534.
79. Li, Y., Kar, A.K., Sodroski, J. (2009b). Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. Journal of Virology 83, 10951-10962.
80. Liao, C.H., Kuang, Y.Q., Liu, H.L., Zheng, Y.T., Su, B. (2007). A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection. AIDS 21, (Suppl 8). S19-26.
81. Lin, D.T., and Lechleiter, J.D. (2002). Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization. Journal of Biological Chemistry 277, 31134-31141.
82. Lindenbach, B.D., and Rice C.M. (2005). Unravelling hepatitis C virus replication from genome to function. Nature. 436, 933-938.
83. Lindenbach, B.D., Thiel, H.J., and Rice, C.M., (2007). Flaviviridae: the virus and their replication, p. 1101-1152. In D. M. Knipe and P. M. Howley (ed.). Fields virology, 5th ed., vol. 1. Lippincott-Raven, Philadelphia, PA.
84. Keyes, L.R., Mariana, G., Bego, Soland M., and Jeor S.S. (2012). Cyclophilin A is required for efficient human cytomegalovirus DNA replication and reactivation Journal of General Virology. 93, 722-732
85. littlejohn, M., locarnini, S., Yuen, L., (2016). Origins and evolution of Hepatitis B Virus and Hepatitis D virus. Cold Spring Harbor Perspectives in Medicine 6, a021360.
86. Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, and Liang C. (2013). The interferoninducible MxB protein inhibits HIV-1 infection. Cell Host and Microbe 14, 398-410.
87. Liu, J., Albers, M.W., Wandless, T.J., Luan, S., Alberg, D.G., Belshaw, P.J., Cohen, P., MacKintosh, C., Klee, C.B., and Schreiber S.L. (1992). Inhibition of T-cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry 31, 3896-3901.
88. Liu, J., Farmer, Jr., J.D., Lane, W.S., Friedman, J., Weissman, I., Schreiber S. L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
89. Liu, N., Song, W., Wang, P., Lee, K., Chan, W., Chen, H., and Cai, Z. (2008). Proteomics analysis of differential expression of cellular proteins in response to avian H9N2 virus infection in human cells. Proteomics 8, 1851-1858.
90. Liu, X., Sun, L., Yu, M., Wang, Z., Xu, C., Xue, Q., Zhang, K., Ye, X., Kitamura, Y., Liu, W. (2009). Cyclophilin A interacts with influenza A virus M1 protein and impairs the early stage of the viral replication. Cell Microbiology. 11, 730-741.
91. Liu, X., Zhao, Z., and Liu, W. (2013). Insights into the Roles of Cyclophilin A during Influenza. Virus Infection. Viruses 5, 182-191.
92. Liu, X., Zhao, Z., Xu, C., Sun, L., Chen, J., Zhang, L., and Liu, W., (2012). Cyclophilin A Restricts Influenza A Virus Replication through Degradation of the M1 Protein. PLoS ONE. 7, e31063.
93. Lodish, H.F., and Kong, N. (1991). Cyclosporin A inhibits an initial step in folding of transferrin within the endoplasmic reticulum. Journal of Biological Chemistry 266,14835-14838.
94. Lu, K.P., Finn, G., Lee, T.H., and Nicholson, L.K. (2007). Prolyl cis-trans isomerization as a molecular timer. Nature Chemical Biology 3, 619-629.
95. Lyles, D.S., McKensie, M., Parce, J.W. (1992). Subunit interactions of vesicular stomatitis virus envelope glycoprotein stabilized by binding to viral matrix protein. Journal of Virology 66, 349-358.
96. Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D. and Littman, D. R. (2010). A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214-217.
97. Martinez-Gonzalez, J., and Hegardt, F.G., (1995). Characterization of a cDNA encoding a cytosolic peptidylprolyl cis-trans-isomerase from Blattella germanica. European journal of Biochemistry 234, 284-92.
98. Mathy, J.E., Ma, S., Compton, T., and Lin, K. (2008). Combinations of cyclophilin inhibitor NIM811 with hepatitis C virus NS3-4A protease or NS5B polymerase inhibitors enhance antiviral activity and suppress the emergence of resistance. Antimicrobial Agents and Chemotherapy 52, 3267-3275.
99. McCaffrey, P.G., Perrino, B.A., Soderling, T.R., Rao, A. (1993) NFATp, a T lymphocyte DNAbinding protein that is a target for calcineurin and immunosuppressive drugs. Jouranl of Biological Chemistry 268, 3747-3752
100. McMinn, P.C., (2012). Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Current Opinion in Virology 2, 199-205.
101. Merker, M.M., Handschumacher, R.E. (1984). Uptake and nature of the intracellular binding of cyclosporin A in a murine thymoma cell line, BW5147. Journal of Immunology 132, 3064-3070.
102. Montague, J.W., Hughes, F.M. Jr, and Cidlowski, J.A. (1997). Native recombinant cyclophilins A, B, and C degrade DNA independently of peptidylprolyl cis-trans-isomerase activity. Potential roles of cyclophilins in apoptosis. Journal of Biological Chemistry 272, 6677-6684.
103. Moss, B. (1968). Inhibition of HeLa cell protein synthesis by the vaccinia virion. Journal of Virology 2, 1028-1037.
104. Naoumov, N.V. (2014) Cyclophilin inhibition as potential therapy for liver diseases. Journal of Hepatology 61, 1166-1174.
105. Neagu, M.R., Ziegler, P., Pertel, T., StrambioDe-Castillia, C., Grutter, C., Martinetti, G., Mazzucchelli, L., Grutter, M., Manz, M.G., and Luban, J. (2009). Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components. The Journal of Clinical Investigation 119, 3035-3047.
106. Ni, S., Yuan, Y., Huang, J., Mao, X., Lv, M., Zhu, J., Shen, X., Pei, J., Lai, L., Jiang, H., and Li, J. (2009). Discovering Potent Small Molecule Inhibitors of Cyclophilin A Using de Novo Drug Design Approach. Journal of Medicinal Chemistry 52, (17): 5295-5298.
107. Nigro, P., Pompilio, G., and Capogrossi, M.C. (2013). Cyclophilin A: a key player for human disease. Cell Death and Disease 4, e888.
108. Nigro, P., Satoh, K., O'Dell, M.R., Soe, N.N., Cui, Z., and Mohan, A. (2011). Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein Edeficient mice. The Journal of Experimental Medicine 208, 53-66.
109. Obchoei, S., Sawanyawisuth, K., Wongkham, C., Kasinrerk, W., Yao, Q., Chen, C., and Wongkham, S. (2015). Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway. Tumour Biology 36, 849-59.
110. Obchoei, S., Wongkhan, S., Wongkham, C., Li, M., Yao, Q., and Chen, C. (2009). Cyclophilin A: potential functions and therapeutic target for human cancer. Medical Science Monitoring 15, 221-232.
111. Okamoto, T., Nishimura, Y., Ichimura, T., Suzuki, K., Miyamura, T., Suzuki, T., Moriishi, K., and Matsuura Y., (2006). Hepatitis C virus RNA replication is regulated by FKBP8 and Hsp90. EMBO Jouranl 25, 5015-5025.
112. Pan, H., Luo, C., Li, R., Qiao, A., Zhang, L., Mines, M., Nyanda, A.M., Zhang, J., and Fan, G.H. (2008). Cyclophilin A is required for CXCR4-mediated nuclear export of heterogenous nuclear ribonucleaoprotein A2 activation and nuclear translocation of ERK1/2, and chemotactic cell migration. Journal of Biological Chemistry 283, 623-637.
113. Patient, R., Hourioux, C., Sizaret, P.Y., Trassard, S., Sureau, C., and Roingeard, P. (2007). Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking, Journal of Virology 81, (8) 3842-51.
114. Pemberton, T.J., and Kay, J.E. (2005). Identification and Comparative Analysis of the Peptidyl-Prolyl Cis/trans Isomerase Repertoires of H. Sapiens, D. Melanogaster, C. Elegans, S. Cerevisiae and Sz. Pombe. Comp. Funct. Genomics 6, 277-300.
115. Pfefferle, S., Schöpf, J., Kögl, M., Friedel, C., Müller, M.A., Stellberger, T., von Dall'Armi, E., Herzog, P., Kallies, S., Niemeyer, D., Ditt, V., Kuri, T., Züst, R., Schwarz, F., Zimmer, R., Steffen, I., Weber, F., Thiel, V., Herrler, G., Thiel, H.-J., Schwegmann-Weßels, C., Pöhlmann, S., Haas, J., Drosten, C., and von Brunn, A., (2011). The SARS-Coronavirus-host interactome: identification of cyclophilins as target for pan-Coronavirus inhibitors. PLoS Pathogens 7 (10), e1002331.
116. Phillips, S., Chokshi, S., Chatterji, U., Riva, A., Bobardt, M., Williams, R., Gallay, P., and Naoumov N.V. (2015). Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production. Gastroenterology 148, 403-414.
117. Pushkarsky, T., Zybarth, G., Dubrovsky, L., Yurchenko, V., Tang, H., Guo, H., Toole, B., Sherry, B., and Bukrinsky, M. (2001). CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A. Proceedings of the National Academy of Sciences of the United States of America 98, (11):6360-5.
118. Qing, J., Wang, Y., Sun, Y., Huang, J., Yan, W., Wang, J., Su, D., Ni, C., Li, J., Rao, Z., Liu, L., and Lou, Z. (2014). Cyclophilin A Associates with Enterovirus-71 Virus Capsid and Plays an Essential Role in Viral Infection as an Uncoating Regulator. PLoS Pathogens 10,(10): e1004422.
119. Qing, M., Yang, F., Zhang, B., Zou, G., Robida, J. M., Yuan, Z., Tang, H. and Shi, P. Y. (2009). Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein. Antimicrobial Agents and Chemotherapy 53, 3226-3235.
120. Qiu, L., Jiang, S., Huang, J., Wang, W., Zhu, C., and Su, T. (2009). Molecular cloning and mRNA expression of cyclophilin A gene in black tiger shrimp (Penaeus monodon). Fish and Shellfish Immunology 26, 115-121.
121. Ranganathan, S., Singh, S., Poh, C.L., and Chow, V.T. (2002). The hand, foot and mouth disease virus capsid: Sequence analysis and prediction of antigenic sites from homology modelling. Applied Bioinformatics 1, 43-52.
122. Rasaiyaah, J., Tan, C.P., Fletcher, A.J., Price, A.J, Blondeau, C., Hilditch, L., Jacques, D.A., Selwood, DL, James LC, Noursadeghi M, and Towers GJ. (2013) HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503, 402-405
123. Rits, M.A., vanDort, K.A., and Kootstra, N.A. (2008). Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection. PLoS One 3, e3975.
124. Rosenwirth, B., Billich, A., Datema, R., Donatsch, P., Hammerschmid, F., Harrison, R., Hiestand, P., Jaksche, H., Mayer, P., and Peichl, P. (1994). Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrobial Agents and Chemotherapy 38, 1763-1772.
125. Rossmann, M.G. (1989). The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance. Journal of Biological Chemistry 264,14587-14590.
126. Ryffel, B., Woerly, G., Greiner, B., Haendler, B., Mihatsch, M. J., and Foxwell B. M. (1991). Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology 72, 399-404.
127. Salonen, A., Ahola, T., and Kaariainen L. (2005). Viral RNA replication in association with cellular membranes. Current Topics in Microbiology and Immunology 285, 139-173.
128. Saphire, A.C., Bobardt, M.D., and Gallay, P.A. (1999). Host cyclophilin A mediates HIV-1 attachment to target cells via heparans. EMBO Journal 18, 6771-6785.
129. Saphire, A.C., Bobardt, M.D., and Gallay, P.A. (2000). Human immunodeficienc virus type 1 hijacks host cyclophilin A for its attachment to target cells. Immunological Research 21, 211-7.
130. Satoh, K., Nigro, P., Matoba, T., O'Dell, M.R., Cui, Z., Shi, X., Mohan, A., Yan, C., Abe, J., Illig, K.A., Berk, B.C. (2009). Cyclophilin A enhances vascular oxidative stress and the development of angiotensin IIinduced aortic aneurysms. Nature medicine 15, (6)649-656.
131. Schaller, T., Ocwieja, K.E., Rasaiyaah, J., Price, A.J., Brady, T.L., Roth, S.L., Hué, S., Fletcher, A.J., Lee, K., KewalRamani V.N., Noursadeghi, M., Jenner, R.G., James, L.C., Bushman, F.D, and Towers, G.J. (2011). HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathogens 7, (12): e1002439.
132. Schneidewind, A., Brockman, M.A., Yang, R., Adam, R.I., Li, B., LeGall, S., Rinaldo, C.R., Craggs, S.L., Allgaier, R.L., Power, K.A., Kuntzen, T., Tung, C.S., LaBute, M.X., Mueller, S.M., Harrer, T., McMichael, A.J., Goulder, P.J., Aiken, C., Brander, C., Kelleher, A.D., and Allen, T.M. (2007). Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. Journal of Virology 81, 12382-12393.
133. Schwartz, M., Chen, J., Janda, M., Sullivan, M., den Boon, J., and Ahlquist, P. (2002). A positive-strand RNA virus replication complex parallels form and function of retrovirus capsids. Molecular Cell 9, 505-514.
134. Shah, V.B., and Aiken, C. (2014) Gene Expression Analysis of a Panel of Cell Lines That Differentially Restrict HIV-1 CA Mutants Infection in a Cyclophilin ADependent Manner. PLoS ONE 9, e92724.
135. Shah, V.B., Shi, J., Hout, D.R., Oztop, I., Krishnan, L., Ahn, J., Shotwell, M.S., Engelman, A., and Aiken, C. (2013). The host proteins transportin SR2/TNPO3 and cyclophilin A exert opposing effects on HIV-1 uncoating. Journal of Virology 87, 422-32
136. Sherry, B., Zybarth, G., Alfano, M., Dubrovsky, L., Mitchell, R., Rich, D., Ulrich, P., Bucala, R., Cerami, A., and Bukrinsky, M. (1998) Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 95, 1758-1763.
137. Sokolskaja, E., Olivari, S., Zufferey, M., Strambio-De-Castillia, C., Pizzato, M., and Luban, J. (2010). Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions. Journal of Virology 84, (9):4851-5.
138. Song, J., Lu, Y.C., Yokoyama, K., Rossi, J., and Chiu, R. (2004). Cyclophilin A is required for retinoic acid-induced neuronal differentiation in p19 cells. Journal of Biological Chemistry 279, 24414-24419.
139. Song, X., Wang, L., Song, L., Zhao, J., Zhang, H., Zheng, P., Qiu, L., Liu, X., and Wu, L. (2009). A cyclophilin A inducible expressed in gonad of zhikong scallop Chlamys farreri. Molecular Biology Reports 36, 1637-1645.
140. Stone, M.S., Jia, W. D., Heo, T., Meyer, K. and Konan V. (2007). Participation of rab5, an early endosome protein, in hepatitis C virus RNA replication machinery. Journal of Virology 81, 4551-4563.
141. Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D.J., Sundquist, W.I., Sodroski, J. (2006). Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proceedings of the National Academy of Sciences of the United States of America 103, 5514-5519.
142. Sun, S., Guo, M., Zhang, J.B., Ha, A., Yokoyama, K.K., and Chiu, R.H. (2014). Cyclophilin A (CypA) Interacts with NF-kB Subunit, p65/RelA, and Contributes to NF-kB Activation Signaling. PLoS ONE 9, e96211.
143. Taigen, T., DeWindt, L. J., Lim, H. W., Molkentin, J. D. (2000). Targeted inhibition of calcineurin prevents agonist induced cardiomyocyte hypertrophy. Proceedings of the National Academy of Sciences of the United States of America 97, 1196-1201.
144. Takemura, T., Kawamata, M., Urabe, M., and Murakami, T. (2013). Cyclophilin Adependent restriction to capsid N121K mutant human immunodeficiency virus type 1 in a broad range of cell lines. Journal of Virology 87, 4086-4090.
145. Tian, X., Zhao, C., Zhu, H., She, W., Zhang, J., Liu, J., Li, L., Zheng, S., Wen, Y., and Xie, Y., (2010). Hepatitis B Virus (HBV) Surface Antigen Interacts with and Promotes Cyclophilin A Secretion: Possible Link to Pathogenesis of HBV Infection. Journal of virology 84, (7): 3373-81.
146. Wainberg, M.A., Dascal, A., Blain, N., Fitz-Gibbon, L., Boulerice, F., Numazaki, K., and Tremblay, M. (1988). The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood 72, 1904-1910.
147. Walsh, C., Zydowsky, L., and McKeon, F.D. (1992). Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction. The Journal of Biological Chemistry 267, 13115-13118.
148. Wang, C., Gale, M., Keller, B. C., Huang, H., Brown, M. S., Goldstein, J. L., and Ye J., (2005). Identification of FBL2 as a geranylgeranylated cellular protein required for hepatitis C virus RNA replication. Molecular Cell 18, 425-434.
149. Wang, L., Wang, C.H., Jia, J.F., Ma, X.K., Li, Y., Zhu, H.B., Tang, H., Chen, Z.N., and Zhu, P. (2010). Contribution of cyclophilin A to the regulation of inflammatory processes in rheumatoid arthritis. Journal of Clinical Immunology 30, 24-33.
150. Wang, P., and Heitman, J. (2005).The cyclophilins. Genome Biology 6, 226.
151. Wang, X., Peng, W., Ren, J., Hu, Z., Xu, J., Lou, Z., Li, X., Yin, W., Shen, X., Porta, C., Walter, S. T., Evans, G., Axford, D., Owen, R., Rowlands, D. J., Wang, J., Stuart, D. I., Fry, E. E., and Rao, Z. (2012). A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71. Nature Structural and Molecular Biology 19, 424-429.
152. Watashi, K. (2010). Alisporivir, a cyclosporin derivative that selectively inhibits cyclophilin, for the treatment of HCV infection. Current opinion in investigational drugs 11, 213-224.
153. Watashi, K., Ishii, N., Hijikata, M., Inoue, D., Murata, T., Miyanari, Y., and Shimotohno, K. (2005) Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Molecular Cell 19, 111-22.
154. Wiegers, K., Rutter, G., Schubert, U., Grättinger, M. and Krausslich, H.G. (1999). Cyclophilin A incorporation is not required for human immunodeficiency type 1 particle maturation and does not destabilize the mature capsid. Virology 257, 261-274.
155. Wise, H.M., Barbezange, C., Jagger, BW., Dalton, R.M., Gog, J.R., Curran, M.D., Taubenberger, J.K., Anderson, E.C., and Digard, P. (2011). Overlapping signals for translational regulation and packaging of influenza A virus segment 2. Nucleic Acids Research 39, 7775-90.
156. Wohlfarth, C., and Efferth, T. (2008). Natural products as promising drug candidates for the treatment of hepatitis B and C. Acta Pharmacologica Sinica 30, 25-30.
157. Xu, Q., Leiva, M. C., Fischkoff, S. A., Handschumacher, R. E., and Lyttle C. R. (1992). Leukocyte chemotactic activity of cyclophilin. The Journal of Biological Chemistry 267, 11968-11971.
158. Yan, W., Qing, J., Mei H, Mao, F., Huang, J., Zhu, J., Jiang, H., Liu, L., Zhang, L. and Li, J. (2015). Discovery of Novel Small Molecule Anti-HCV Agents via the CypA Inhibitory Mechanism Using O-Acylation-Directed Lead Optimization. Molecules 20, 10342-59.
159. Yan, W., Qing, J., Mei, H., Nong, J., Huang, J., Zhu, J., Jiang, H., Liu, L., Zhang, L., Li, J., (2015). Identification, synthesis and pharmacological evaluation of novel anti-EV71 agents via cyclophilin A inhibition. Bioorganic and Medicinal Chemistry Letters 25, 5682-5686.
160. Yang, S., Jyothi, K.R., Lim, S., Choi, T.G., Kim, J.H., Akter, S., Jang, M., Ahn, H.J., Kim, H.Y., Windisch, M.P., Khadka, D.B., Zhao, C., Jin Y., Kang, I., Ha, J., Oh, B.C., Kim, M., Kim, S.S., and Cho, W.J. (2015). Structure-Based Discovery of Novel Cyclophilin A Inhibitors for the Treatment of Hepatitis C Virus Infections. Journal of Medicinal Chemisrty 58, 9546-61.
161. Yeh, H.Y., Shoemaker, C.A., and Klesius, P.H. (2013). Chemotactic activity of channel catfish, Ictalurus punctatus (Rafinesque), recombinant cyclophilin A. Journal of Fish Diseases. 36, 1041-1046.
162. Ylinen, L.M., Schaller, T., Price, A., Fletcher, A.J., Noursadeghi, M., James, L.C., Towers, G.J. (2009). Cyclophilin A levels dictate infection efficiency of human immunodeficiency virus type 1 capsid escape mutants A92E and G94D. Journal of Virology 83, 2044-7
163. Yurchenko, V., Constant, S., and Bukrinsky, M. (2006). Dealing with the family: CD147 interactions with cyclophilins. Immunology 117, 301-309.
164. Zhao, C., Fang, C.Y., Tian, X.C., Wang, L., Yang, P.Y., and Wen, Y.M. (2007). Proteomic analysis of hepatitis B surface antigen positive transgenic mouse liver and decrease of cyclophilin A. Journal of medical Virology 79, (10): 1478-84.
165. Zhou, D., Mei, Q., Li, J., He, H. (2012). Cyclophilin A and viral infections. Biochemical and Biophysical Research Communications 424, 647-650.
166. Zhu, C., Wang, X., Deinum, J., Huang, Z., Gao, J., Modjtahedi, N., Neagu, M.R, Nilsson, M, Eriksson, P.S., Hagberg, H., Luban, J., Kroemer, G., and Blomgren, K. (2007). Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. The Journal of Experimental Medicine 204, 1741-8.